Potassium Citrate
Back to searchMolecule Structure
Scientific Name
Potassium Citrate
Description of the Drug
Potassium citrate is an agent used to manage renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09125
http://www.drugbank.ca/drugs/DB09125
Brand Name(s)
Potassium Citrate, Urocit-K
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Eywa Pharma Inc, Mission Pharmacal Co, Ascent Pharmaceuticals Inc, Ut Southwestern Medctr, Ani Pharmaceuticals Inc, Bionpharma Inc, Strides Pharma Global Pte Ltd, Zydus Pharmaceuticals Usa Inc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL47867 | |||
DrugBank | DB09125 | |||
PubChem: Thomson Pharma | 14898662 | |||
PubChem | 13344 | |||
Nikkaji | J7.148J | |||
EPA CompTox Dashboard | DTXSID8027325 | |||
ChemicalBook | CB4134347 | CB7134348 | ||
rxnorm | POTASSIUM CITRATE MONOHYDRATE | UROCIT-K | POTASSIUM CITRATE ANHYDROUS | POTASSIUM CITRATE |
ChEBI | 64733 |